Redmile Biopharma Investments III, L.P.
San francisco, Ca
Redmile Biopharma Investments III, L.P. is a venture capital fund managed by Redmile Biopharma Investments. Its SEC Form D filing reports $500.2M raised, 77 investors, and a first sale on December 23, 2020.
Amount Raised
$500.2M
Target Size
—
Investors
77
Date Filed
2021-01-04
Dry powder breakdown
Est. Remaining
Fully deployed
Deployed
$500.2M
100% deployedVintage ≥ 4 years
Filing details
Fund vehicleRedmile Biopharma Investments III, L.P.
IndustryVenture Capital Fund
AddressLetterman Digital Arts Center, San Francisco, CA
Phone415-489-9980
Accession #0001820505-21-000002
Related personsView on SEC EDGAR ↗